Satsuma Financial Statements From 2010 to 2025
| STSADelisted Stock | USD 1.10 0.01 0.90% |
Check Satsuma Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Satsuma Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Satsuma financial statements analysis is a perfect complement when working with Satsuma Pharmaceuticals Valuation or Volatility modules.
Satsuma |
Satsuma Pharmaceuticals Company Return On Equity Analysis
Satsuma Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Satsuma Pharmaceuticals Return On Equity | -1.04 |
Most of Satsuma Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Satsuma Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Satsuma Pharmaceuticals has a Return On Equity of -1.0404. This is 95.66% lower than that of the Pharmaceuticals sector and 97.15% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Satsuma Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Satsuma Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Satsuma Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Satsuma Pharmaceuticals competition to find correlations between indicators driving Satsuma Pharmaceuticals's intrinsic value. More Info.Satsuma Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Satsuma Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Satsuma Pharmaceuticals Financial Statements
Satsuma Pharmaceuticals stakeholders use historical fundamental indicators, such as Satsuma Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Satsuma Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Satsuma Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Satsuma Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Satsuma Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. Satsuma Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 25 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |